Skip to main content
XCUR
NASDAQ Life Sciences

Exicure to Sell GPC-100 Program to Korea's GPCRT for ~$4.8M Cash

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.081
Mkt Cap
$6.676M
52W Low
$0.777
52W High
$9.48
52W Position info
39% above low
Off High info
89% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

XCUR sits 39% above its 52-week low of $0.777 on elevated volume (2.6× avg).

Summary

Exicure agreed on November 4 to sell its GPC-100 (burixafor) program assets to Korea-based GPCRT Inc. for KRW 6.5 billion, about $4.8 million in cash. The price is roughly seven times the company's entire market value, and it comes as Exicure's Q2 10-Q showed cash down to $1.7M with a going concern warning and stockholders' equity below Nasdaq's minimum. Payment is staged: KRW 500 million already paid and credited, KRW 2.0 billion due by November 16, 2026, and KRW 4.0 billion at closing. GPCRT takes over the License and Collaboration Agreement obligations, including future milestones and royalties, and absorbs GPC-100 program costs from September 1, 2026, while Exicure keeps pre-September liabilities. Closing still needs third-party consents, a waiver and release from GPCR Therapeutics, Inc., and any required stockholder approval, so the cash is not yet certain. The sale is part of the strategic-alternatives review and follows the September 16 Nasdaq extension to December 2, 2026 to regain equity compliance.

Updates

  1. · SEC 8-K — The KRW 6.5 billion price is payable as a KRW 500 million credited deposit, KRW 2.0 billion interim payment due by November 16, 2026, and KRW 4.0 billion at closing.

At the time of this announcement, XCUR was trading at $1.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $0.78 to $9.48. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

XCUR - Latest Insights

XCUR
Nov 10, 2026, 3:50 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $0.9962 info
Change: -$0.0848 (-8%) info
Market Cap: $7.07M info
XCUR
Nov 02, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $0.9962 info
Change: -$0.0638 (-6%) info
Market Cap: $7.07M info
XCUR
Sep 16, 2026, 10:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $0.9962 info
Change: -$0.3088 (-24%) info
Market Cap: $7.07M info
XCUR
Aug 14, 2026, 3:27 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $0.9962 info
Change: -$0.2638 (-21%) info
Market Cap: $7.07M info
XCUR
Jul 17, 2026, 4:39 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.63
Real-time Price: $0.9962 info
Change: -$0.6338 (-39%) info
Market Cap: $7.07M info